Zantac was a very popular drug that was used to treat stomach acid issues. The most common issue it was used for was heartburn. It could treat it when it occurred, and it could also prevent it in some cases. Other issues it was sometimes used for included GERD, or gastroesophageal reflux disease, and stomach ulcers.
However, the drug made headlines in the spring when it was recalled by the Food and Drug Administration (FDA). Have you wondered why it was pulled from shelves and users were told to stop using it immediately?
The reason is that it may have too much NDMA, or N-Nitrosodimethylamine. This has been classified as a “probable human carcinogen,” which simply means that it may cause cancer in humans and should be avoided when possible as a result.
Why did this issue leap into the public eye? The problem is that, in some ranitidine products like Zantac, storing the drug above room temperature can cause the amount of NDMA to go up. Therefore, when the drug was manufactured, it may have been safe and within legal limits. However, if it was then stored in a hot warehouse or a storeroom before being sold, it could be too contaminated to take safely. These unacceptable NDMA levels may increase the chances that users will develop cancer.
Have you been diagnosed with cancer after using Zantac or other products — Zantac is simply the branded name — without knowing that you were exposing yourself to such a risk? If so, you may want to take the time to look into all of the legal options that you have.